EN DE

Solborn, Inc (035610) Fair Value & Analysis

Industrials · KR · Market cap 131B KRW

SI Solborn, Inc 035610 · KQ
Price4,860 KRW
Fair Value9,280 KRW
Upside+91.0%
Quality47/100
Watch Solborn, Inc for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Highly profitable · 23.7% net margin
Low debt · generates free cash flow
Ranks above peers (8/9)
Moderate moat 63/100
Evidence: Medium Range 6,960 KRW – 11,600 KRW Share as image

Fair value as of: Jul 20, 2026

From 10 valuation models · updated 21 days ago

Fair value updated Jul 20, 2026, revised from 6,850 KRW to 9,280 KRW (+35.5%) since Jun 26, 2026. Share price +20.4% over the past month.

Below-average quality, screening 91% undervalued on our models.

What matters now

  • The price is below even our cautious bear case (6,960 KRW). The market is more pessimistic than our downside scenario.
  • Solid quality (47/100) at a price below fair value, the discount is the argument here, not the business quality.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

10,150 KRW 2,940 KRW Fair Value 9,280 KRW Mar 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 20, 2026.

How to read this chart

60‑month range 2,940 KRW – 10,150 KRW · fair‑value band 6,960 KRW – 11,600 KRW · the 4,860 KRW price screens below the 9,280 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 20, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Solborn, Inc (035610) currently trades at 4,860 KRW, while our model-based Fair Value estimate is 9,280 KRW, implying the stock looks roughly 91.0% undervalued today. The Quality Score stands at 47/100 (below-average quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.

Over the trailing twelve months, Solborn, Inc generated revenue of 131B KRW at a net margin of 23.7%. Revenue grew 42.2% year over year. It earns a return on equity of 17.2%. Fundamentals as of Jul 20, 2026

Our scenario range runs from 6,960 KRW (bear case) to 11,600 KRW (bull case); at 4,860 KRW, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 51% above its 52-week low, currently above its 200-day average. For context, the median of 10 Industrials peers we cover trades at -14% fair-value upside, at 91%, 035610 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF 6,481 KRW 8,465 KRW 11,580 KRW 80
Residual Income 6,801 KRW 7,542 KRW 11,568 KRW 76
Rev-Margin DCF 7,636 KRW 11,290 KRW 15,484 KRW 74
All 10 models by family
DCF Models
Owner Earnings 9,410 KRW 12,653 KRW 18,078 KRW 31
5Y P/E Exit 9,711 KRW 14,793 KRW 20,364 KRW 38
10Y P/E Exit 8,351 KRW 12,289 KRW 16,478 KRW 35
Earnings-Based
Graham-Dodd 5,189 KRW 9,701 KRW 12,046 KRW 54
Multiples
P/E Multiple 12,592 KRW 16,789 KRW 20,987 KRW 63
P/B Multiple 9,730 KRW 12,974 KRW 16,217 KRW 55
Asset-Based
NCAV (Graham) 3,887 KRW 5,209 KRW 7,775 KRW 50
Growth DCF
Growth DCF 6,481 KRW 8,465 KRW 11,580 KRW 80
Rev-Margin DCF 7,636 KRW 11,290 KRW 15,484 KRW 74
Economic Profit
Residual Income 6,801 KRW 7,542 KRW 11,568 KRW 76

Widest divergence: Multiples (12,974 KRW) versus Asset-Based (5,209 KRW). Highest evidence: Growth DCF (80).

Notify me when 035610 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 131B KRW
Revenue growth (YoY) +42.2%
Net margin 23.7%
Return on equity 17.2%
Free cash flow 14.5B KRW FY2025
Operating margin 10.4%
More key figures
EPS growth (YoY) +482%

Figures from reported company fundamentals · as of Jul 20, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 47/100

Of which business quality 48 · Market factors (momentum, volatility) 64

Profitability 43
Margins and returns on capital today
Quality Growth 23
Are margins and returns improving?
Cashflow 55
Earnings quality: real cash, not paper profit
Fin. Strength 77
Balance sheet, leverage, solvency risk
Investment 35
Disciplined investing over empire-building
Low Volatility 70
Calm price path (market factor)
Momentum 56
Price trend over the last 3–12 months (market factor)
52W Momentum 70
Distance to the 52-week high (market factor)
Net Issuance 38
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Solborn, Inc., an investment holding company, engages in the manufacturing and sales of medical equipment in South Korea. The company engages in the PACS and S/W manufacturing, sales, and maintenance; medical device H/W manufacturing, wholesale, and maintenance. It is also involved in provision of newspaper issuance and online information services.

Full company description

Solborn, Inc., an investment holding company, engages in the manufacturing and sales of medical equipment in South Korea. The company engages in the PACS and S/W manufacturing, sales, and maintenance; medical device H/W manufacturing, wholesale, and maintenance. It is also involved in provision of newspaper issuance and online information services. In addition, the company invests in small and medium-sized enterprises and venture companies. Further, it engages in golf related business and real estate leasing business. The company was formerly known as Serome Technology, Inc. Solborn, Inc. was founded in 1994 and is headquartered in Seoul, South Korea.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Solborn, Inc reported revenue of 121B KRW in FY2025 versus 100B KRW in FY2021, a compound +4.8%/yr. Reported net income was 20.9B KRW in FY2025, compounding +4.0%/yr from FY2021.

Growth Quality 80/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
121B KRW
Latest YoY
−1.0%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+8.7%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+8.0%
Avg. growth/yr (24Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+4.1%
Revenue +4.8%/yr
FY21 100B KRW
FY22 93.8B KRW
FY23 120B KRW
FY24 122B KRW
FY25 121B KRW
Net income +4.0%/yr
FY21 17.8B KRW
FY22 −41.7B KRW
FY23 38.2B KRW
FY24 36.9B KRW
FY25 20.9B KRW

Watch 035610: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Solborn, Inc Fair Value". https://www.fairvalue-calculator.com/stock/035610

Peer Group

Conglomerates · 369 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 47 · Below median
Fair Value upside +91% · Top 25%
Return on equity (TTM) 17% · Top 25%
Return on assets 6% · Top 25%
Net margin (TTM) 24% · Top 25%
Operating margin (TTM) 10% · Above median
Revenue growth 42% · Top 25%

Valuation Multiples vs Conglomerates median · lower = cheaper

P/FCF 0.0× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 100 · sector 20
FUTURE 100 · sector 16
PAST 69 · sector 20
HEALTH 100 · sector 88
DIVIDEND 0 · sector 39

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Conglomerates stocks, each showing price versus our Fair Value estimate (as of Jul 20, 2026).

Stock Price Fair Value vs Fair Value
CITIC Limited 0267 HK$11.28 HK$22.56 +100%
SK Inc 034730 580,000 KRW 497,919 KRW -14%
PT Astra International Tbk, ASII 4,810 IDR 9,620 IDR +100%
The Siam Cement Public Company SCC 254.00 THB 199.40 THB -21%
SRF Limited SRF ₹2,875 ₹1,053 -63%
Empresas Copec S.A COPEC 6,330 CLP 10,879 CLP +72%
Posco International Corporation 047050 50,900 KRW 61,248 KRW +20%
Tube Investments of India Limited TIINDIA ₹2,940 ₹559.30 -81%
Doosan Corporation 000155 464,000 KRW 75,620 KRW -84%
Thermax Limited THERMAX ₹4,809 ₹1,087 -77%

Compare Solborn, Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Solborn, Inc (035610) overvalued or undervalued?
As of Jul 20, 2026, our model estimates a fair value of 9,280 KRW versus a price of 4,860 KRW, about +91% (undervalued).
What is the fair value of 035610?
Our model-based fair value for Solborn, Inc is 9,280 KRW (as of Jul 20, 2026), built from audited fundamentals. The current price is 4,860 KRW.
What is the quality score of 035610?
Solborn, Inc has a Quality Score of 47/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Solborn, Inc (035610)?
Solborn, Inc reported trailing-twelve-month revenue of about 131B KRW (latest available figure, as of Jul 20, 2026).
What is the net profit margin of 035610?
The net profit margin of Solborn, Inc is about 23.7%, meaning it keeps roughly 23.7% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Solborn, Inc and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.